Current status: 1129 hESC lines, 7923 hiPSC lines, and 205 clinical studies, and 2405 certificates
Monthly statistic from Jun 1, 2026
Posted on June 1, 2026
| total lines | 9052 |
| hESC lines | 1129 |
| hiPSC lines | 7923 |
| derivation countries | 52 |
| projects | 343 |
| providers | 1053 |
| clinical studies | 205 |
| subclones | 4082 |
| certificates | 2405 |
| cell line certificates | 2246 |
| project certificates | 159 |